Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerations
Open Access
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 10 (2) , 155-160
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialThe Lancet, 1999
- Split activity of interleukin‐10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative stepEuropean Journal of Immunology, 1997
- Development of Cancer Immunotherapies Based on Identification of the Genes Encoding Cancer Regression AntigensJNCI: Journal of the National Cancer Institute, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Multidisciplinary management of advanced primary and metastatic breast cancerCancer, 1994
- Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysisEuropean Journal of Cancer, 1993
- Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelosuppression induced by Multiple Cycles of High-Dose Chemotherapy in Patients With Advanced Breast CancerJNCI: Journal of the National Cancer Institute, 1991